Parker Institute for Cancer Immunotherapy
Search
Search Close

Directory

  • Type

  • Reset Filters

Showing 1 - 24 of 25 Partners

Take an innovative approach to cancer treatment by developing novel T-cell receptor therapies

Conduct innovative clinical trials using novel combinations

Conduct innovative clinical trials using novel combinations

Upgrade the human immune system through T-cell engineering to combat cancer

Evaluate clinical grade flow cytometer to enhance research  

Identify areas of unmet need in breast cancer research and clinical trials

Conduct innovative clinical trials using novel combinations

Support high potential pediatric cancer immuno-oncology projects

Test and validate epigenetic profiling technology

Test and validate mass cytometer for tumor-immune system imaging

Advance cell therapy development by optimizing regulatory processes

Conduct innovative clinical trials using novel vaccine combinations

Understand, predict and prevent insulin-dependent diabetes following checkpoint therapy

Develop curative cell therapies, with a focus on solid tumors

Collect and analyze patient samples to understand autoimmune side effects following checkpoint therapy

Collect and analyze patient samples to understand autoimmune side effects following checkpoint therapy

Investigate using virus-based gene therapy to treat solid tumors

Conduct innovative clinical trials using novel cell therapy treatments  

Understand, predict and prevent insulin-dependent diabetes following checkpoint therapy

Support development of next-generation T-cell immunotherapies